Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Copenhagen | OTHER |
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to identify causes of chest pain in patients experiencing chest pain with no signs of narrowing of the coronary arteries of the heart, and to investigate whether physical exercise can improve coronary microvascular function.
Hypotheses:
The first hypothesis is that in INOCA, with reduced function of microvasculature of the heart, this reduced function also occurs in other organs of the body.
The second hypothesis is that regular physical activity (aerobic exercise training) can improve coronary microvascular function, reduce symptoms, and that there is a parallel improvement in vascular function in other organs of the body.
A significant number of patients suspected of chronic coronary syndrome do not have coronary artery obstruction and in a large proportion of these, their symptoms are attributed to coronary microvascular dysfunction (CMD), a condition known as ischemia with no obstructive coronary artery disease (INOCA). Despite a considerable patient population affected by INOCA, the specific mechanisms underlying CMD are not fully understood, often resulting in a lack of targeted treatment. There is evidence to suggest that exercise capacity is linked to coronary microvascular function, positing that exercise training could potentially reverse microvascular dysfunction and address its mechanistic origins, a hypothesis yet to be explored.
This study aims to identify mechanisms underlying CMD in angina and to assess whether exercise training can improve the condition.
The current study is a randomized controlled trial testing the effect of exercise training in patients with CMD. 100 patients will be randomized 1:1 to exercise training or control. The primary outcome is coronary microvascular function, secondary outcomes include symptoms and microvascular function in cutaneous tissue, skeletal muscle, and adipose tissue.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise | Active Comparator | The exercise intervention consists of supervised training 40-50 minutes x 3 weekly for 12 weeks. |
|
| Control | No Intervention | The participants who are randomized to the no-training group will be offered exercise train-ing after the intervention is completed. Participants will be encouraged to not change their lifestyle or medication throughout the study period. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise training | Other | The training sessions are consist of cycling and as follows: a 10 min warm-up at a light intensity, 20-35 min of cycling exercise in intervals at varying intensities from light (~60% of max heart rate) to more intensive (80-90% of max heart rate) and ending with 5 min of warm-down at a light intensity. The training intensity will be progressive during the course of the intervention period. The cycling training sessions are supervised . Home training is allowed up to once a week if participants are able to adhere to the prescribed intensity levels. Training sessions are closely monitored to ensure effectiveness and safety. This includes heart rate monitoring, perceived exertion assessment. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Myocardial Blood Flow Reserve (MBFR) | Change in MBFR assessed by [15O]H2O-PET-scan | From baseline and after 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in symptom burden assessed by Seattle Angina Questionnaire | Seattle angina questionnaire/selfreported (scale range 0-100, 0=poor and 100=excellent health status) | From baseline and after 3 months |
| Change in exercise capacity |
| Measure | Description | Time Frame |
|---|---|---|
| Vascular Function Adaptations | Changes in Arterial compliance (C = ΔV/ ΔP) calculated from intraarterial pressure ΔP and arterial diameter (ΔD) measured by ultrasound Doppler | From baseline and after 3 months |
| Changes in skin microvascular function |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eva Prescott, MD, DMSc | Contact | 004522572614 | Eva.Irene.Bossano.Prescott@regionh.dk | |
| Mads Fischer, MSc | Contact | +45 23 46 36 66 | mf@nexs.ku.dk |
| Name | Affiliation | Role |
|---|---|---|
| Eva Prescott, MD, DMSc | University of Copenhagen | Principal Investigator |
| Ylva Hellsten | University of Copenhagen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57, Frederiksberg, Denmark, 2000 | Not yet recruiting | Copenhagen | 2400 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jul 29, 2024 | Jul 29, 2024 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D017566 | Microvascular Angina |
| ID | Term |
|---|---|
| D000787 | Angina Pectoris |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| D000076663 | Endurance Training |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Randomized controlled trial in which 100 angina patients with reduced flow reserve (INOCA patients) are randomized 1:1 to either exercise training or control (no exer-cise training).
Not provided
Not provided
Not provided
Not provided
|
|
Oxygen uptake during exhaustive exercise
| From baseline and after 3 months |
| Change in global rest perfusion in patients with angina symptoms and CMD | Change in Myocardial Blood Flow assessed by [15O]H2O-PET-scan | From baseline and after 3 months |
| Change in global stress perfusion in patients with angina symptoms and CMD | Change in hyperemic Myocardial Blood Flow assessed by [15O]H2O-PET-scan | From baseline and after 3 months |
Hand microcirculatory blood flow assessed by Laser Speckle Contrast Imaging
| From baseline and after 3 months |
| Change in plasma levels of markers related to vascular function | Plasma levels of markers related to vascular function assessed by Mesoscale/ELISA | From baseline and after 3 months |
| Changes in Arterial Blood Pressure | Assessed by automated blood pressure at rest | From baseline and after 3 months |
| Change in plasma Lipids | Conducted through clinical chemical analysis to measure levels of HDL, and triglycerides in the blood, providing insights into lipid profiles. | From baseline and after 3 months |
| Changes in Plasma Levels of Inflammatory Markers | Measured using Mesoscale/ELISA/O-Link platforms to evaluate the presence and levels of inflammatory markers, indicating systemic inflammation. | From baseline and after 3 months |
| Proteomic and transcriptomic analyses | Changes in gene and protein expressions patterns in small arteries | From baseline and after 3 months |
| Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57 | Recruiting | Frederiksberg | 2000 | Denmark |
|
| D014652 |
| Vascular Diseases |
| D005081 | Exercise Therapy |
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
| D064797 | Physical Conditioning, Human |